Previous studies have demonstrated that FGF21 and adiponectin are involved in the regulation of insulin sensitivity [27–29], and disturbance of the FGF21-adiponectin pathway abrogates FGF21-induced improvement of insulin resistance [14]. The gene discussed is INS; the disease is Insulin resistance.